Abstract
Several severe congenital cardiomyopathies are known to be associated with deficiencies in long-chain fatty acid transport and oxidation. Our studies are focused on a key enzyme in the regulation of intracellular long-chain fatty acid transport: carnitine palmitoyltransferase 1. Of this enzyme, two isoforms are expressed in the neonatal heart: L-CPT1 (the “liver-type” isoform) and M-CPT1 (the “muscle-type” isoform). It is known from studies in rats that chemical inhibition of both CPT1 isoforms results in hypertrophy of the cardiomyocytes, leading to an increase in heart-weight of up to 25%. With the aid of expressed sequence tag database analyses, cDNA- and genomic sequence information, we analysed the human gene for M-CPT1 in detail, and obtained partial clones of the murine genes for both CPT1 isoforms. We now started the development of a conditional knockout model to analyse and dissect deficiencies in these genes.
While of the other mitochondrial components of the carnitine system deficiencies are known, some with severe cardiac consequences, M-CPT1 deficiencies have never been described. This suggests that M-CPT1 deficiency either (1) has not been recognised within the pool of congenital disorders, (2) is detrimental in an early stage of reproduction or embryogenesis, or (3) does not lead to physiological problems, probably due to the existence of a rescue system. If (1) is the case, the phenotypic effects of M-CPT1 deficiency have to be studied in order to generate criteria for clinical decision making and diagnosis. Option (2) demonstrates the necessity to use novel vector systems to create conditional gene disruptions. Hypothesis (3) implies a possible role for L-CPT1, and a knockout model allows a study of the interaction between the genes for L-CPT1 and M-CPT1. Applicable strategies to develop such a model system will be discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Neely, J.R., Rovetto, M.J. & Oram, J.F. (1972). Prog Cardiovasc Dis 15:289–329. Myocardial utilization of carbohydrate and lipids.
McGarry, J.D. & Brown, N.F. (1997). Eur J Biochem 244:1–14. The mitochondrial carnitine palmitoyl-transferase system. From concept to molecular analysis.
Brown, N.F., Weis, B.C., Husti, J.E., Foster, D.W. & McGarry, J.D. (1995). J Biol Chem 270:8952–8957. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart.
Britton, C.H., Schultz, R.A., Zhang, B., Esser, V., Foster, D.W. & McGarry, J.D. (1995). Proc Natl Acad Sci U S A 92:1984–1988. Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene.
Britton, C.H., Mackey, D.W., Esser, V., Foster, D.W., Burns, D.K., Yarnall, D.P., Froguel, P. & McGarry, J.D. (1997). Genomics 40:209–211. Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B).
van der Leij, F.R., Takens, J., van der Veen, A.Y., Terpstra, P. & Kuipers, J.R.G. (1997). Biochim Biophys Acta 1352:123–128. Localization and intron usage analysis of the human CPT1B gene for muscle type carnitine palmitoyltransferase I.
Coates, P.M. & Tanaka, K. (1992). J Lipid Res 33:1099–1110. Molecular basis of mitochondrial fatty acid oxidation defects.
Kelly, D.P. & Strauss, A.W. (1994). N Engl J Med 330:913–919. Inherited cardiomyopathies.
Schwartz, M.L., Cox, G.F., Lin, A.E., Korson, M.S., Perez-Atayde, A., Lacro, R.V. & Lipshultz, S.E. (1996). Circulation 94:2021–2038. Clinical approach to genetic cardiomyopathy in children.
Olpin, S.E., Bonham, J.R., Downing, M., Manning, N.J., Pollitt, R.J., Sharrard, M.J. & Tanner, M.S. (1997). J Inherit Metab Dis 20:714–715. Carnitine-acylcarnitine translocase deficiency—a mild phenotype.
DiMauro, S. & DiMauro, P.M. (1973). Science 182:929–931. Muscle carnitine palmityltransferase deficiency and myoglobinuria.
Stanley, C.A., Hale, D.E., Berry, G.T., Deleeuw, S., Boxer, J. & Bonnefont, J.P. (1992). N Engl J Med 327:19–23. Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane.
Pande, S.V., Brivet, M., Slama, A., Demaugre, F., Aufrant, C. & Saudubray, J.M. (1993). J Clin Invest 91:1247–1252. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.
Niezen-Koning, K.E., van Spronsen, F.J., Ijlst, L., Wanders, R.J., Brivet, M., Duran, M., Reijngoud, D.J., Heymans, H.S. & Smit, G.P. (1995). J Inherit Metab Dis 18:230–232. A patient with lethal cardiomyopathy and a carnitine-acylcarnitine translocase deficiency.
Demaugre, F., Bonnefont, J.P., Colonna, M., Cepanec, C., Leroux, J.P. & Saudubray, J.M. (1991). J Clin Invest 87:859–64. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.
Hug, G., Bove, K.E. & Soukup, S. (1991). N Engl J Med 325:1862–1864. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II.
Bougneres, P.F., Saudubray, J.M., Marsac, C., Bernard, O., Odievre, M. & Girard, J. (1981). J Pediatr 98:742–746. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency.
Demaugre, F., Bonnefont, J.P., Mitchell, G., Nguyen, H.N., Pelet, A., Rimoldi, M., Di, D.S. & Saudubray, J.M. (1988). Pediatr Res 24:308–311. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities.
Haworth, J.C., Demaugre, F., Booth, F.A., Dilling, L.A., Moroz, S.P., Seshia, S.S., Seargeant, L.E. & Coates, P.M. (1992). J Pediatr 121:553–557. Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family.
Bergman, A.J., Donckerwolcke, R.A., Duran, M., Smeitink, J.A., Mousson, B., Vianey-Saban, C. & Poll-The, B.T. (1994). Pediatr Res 36:582–588. Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.
Schaefer, J., Jackson, S., Taroni, F., Swift, P. & Turnbull, D.M. (1997). J Neurol Neurosurg Psychiatry 62:169–176. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyl-transferase deficiency: implications for diagnosis and therapy.
Tein, I., Demaugre, F., Bonnefont, J.P. & Saudubray, J.M. (1989). J Neurol Sci 92:229–245. Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Hulsmann, W.C., Peschechera, A., Schneijdenberg, C.T. & Verkleij, A.J. (1994). Cardioscience 5:193–197. Comparison of the effects of carnitine palmitoyltransferase-1 and-2 inhibitors on rat heart hypertrophy.
Rupp, H., Elimban, V. & Dhalla, N.S. (1992). Faseb J 6:2349–2353. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor.
Brown, N.F., Hill, J.K., Esser, V., Kirkland, J.L., Corkey, B.E., Foster, D.W. & McGarry, J.D. (1997). Biochem J 327:225–31. Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation. Inter-tissue and interspecies expression of CPT I and CPT II enzymes.
Braun, R.E., Behringer, R.R., Peschon, J.J., Brinster, R.L. & Palmiter, R.D. (1989). Nature 337:373–376. Genetically haploid spermatids are phenotypically diploid.
Phelan, M.C., Thomas, G.R., Saul, R.A., Rogers, R.C., Taylor, H.A., Wenger, D.A. & McDermid, H.E. (1992). Am J Med Genet 43:872–876. Cytogenetic, biochemical, and molecular analyses of a 22q13 deletion.
Nesslinger, N.J., Gorski, J.L., Kurczynski, T.W., Shapira, S.K., Siegel-Bartelt, J., Dumanski, J.P, Cullen, R.F., Jr., French, B.N. & McDermid, H.E. (1994). Am J Hum Genet 4:464–472. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22ql3.3.
Doheny, K.F., McDermid, H.E., Harum, K., Thomas, G.H. & Raymond, G.V. (1997). J Med Genet 34:640–644. Cryptic terminal rearrangement of chromosome 22q l3.32 detected by FISH in two unrelated patients.
McGarry, J.D., Mills, S.E., Long, C.S. & Foster, D.W. (1983). Biochem J 214:21–28. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat.
Thomas, K.R., Folger, K.R. & Capecchi, M.R. (1986). Cell 44:419–428. High frequency targeting of genes to specific sites in the mammalian genome.
James, J.F., Hewett, T.E. & Robbins, J. (1998). Circ Res 82:407–415. Cardiac physiology in transgenic mice.
Sauer, B. & Henderson, N. (1988). Proc Natl Acad Sci U S A 85:5166–5170. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.
Gu, H., Marth, J.D., Orban, PC., Mossmann, H. & Rajewsky, K. (1994). Science 265:103–106. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.
Barinaga, M. (1994). Science 265:26–28. Knockout mice: round two.
Schwenk, F., Baron, U. & Rajewsky, K. (1995). Nucleic Acids Res 23:5080–5081. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.
Chen, J., Kubalak, S. & Chien, K. (1998). Development 125:1943–1949. Ventricular muscle-restricted targeting of the RXR(alpha) gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis.
Wang, Y., Krushel, L.A. & Edelman, G.M. (1996). Proc Natl Acad Sci U S A 93:3932–3936. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Agah, R., Frenkel, P.A., French, B.A., Michael, L.H., Overbeek, P.A. & Schneider, M.D. (1997). J Clin Invest 100:169–179. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.
Yamazaki, N., Yamanaka, Y., Hashimoto, Y., Shinohara, Y., Shima, A. & Terada, H. (1997). FEBS Lett 409:401–406. Structural features of the gene encoding human muscle type carnitine palmitoyltransferase I.
Wang, D., Harrison, W., Buja, L.M., Elder, F.F. & McMillin, J.B. (1998). Genomics 48:314–323. Genomic DNA sequence, promoter expression, and chromosomal mapping of rat muscle carnitine palmitoyl-transferase I.
Park, E.A., Steffen, M.L., Song, S., Park, V.M. & Cook, G.A. (1998). Biochem J 330:217–24. Cloning and characterization of the promoter for the liver isoform of the rat carnitine palmitoyltransferase I (L-CPT I) gene.
Torres, R.M. & Kühn, R. Laboratory protocols for conditional gene targeting. Oxford University Press, Oxford, New York and Tokyo. (1997).
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. & Prasher, D.C. (1994). Science 263:802–805. Green fluorescent protein as a marker for gene expression.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
van der Leij, F.R., Drijfholt, A., Kuipers, J.R.G. (2002). Rationale for a Conditional Knockout Mouse Model to Study Carnitine Palmitoyltransferase I Deficiencies. In: Quant, P.A., Eaton, S. (eds) Current Views of Fatty Acid Oxidation and Ketogenesis. Advances in Experimental Medicine and Biology, vol 466. Springer, Boston, MA. https://doi.org/10.1007/0-306-46818-2_44
Download citation
DOI: https://doi.org/10.1007/0-306-46818-2_44
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46200-9
Online ISBN: 978-0-306-46818-6
eBook Packages: Springer Book Archive